Watchlist Price Alert

Theriva Biologics Inc. (TOVX)

AMEX: TOVX · Real-Time Price · USD

0.62

-0.19 (-23.46%)

At close: May 08, 2025, 3:59 PM

0.63

0.93%

Pre-market: May 09, 2025, 06:57 AM EDT

Theriva Biologics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-25.65M	-18.35M	-19.68M	-14.27M	-10.12M	-15.38M	-13.42M	-15.49M	-27.8M
Depreciation & Amortization	137K	135K	85K	87K	201K	240K	272K	245K	157K
Stock-Based Compensation	671K	552K	475K	416K	350K	340K	2.07M	3.41M	4.01M
Other Working Capital	603K	2.47M	-421K	1.24M	-1.35M	-427K	-1.21M	2.35M	9.57M
Other Non-Cash Items	7.91M	-2M	2.27M	952K	178K	72K	71K	-10.74M	-11.41M
Deferred Income Tax	n/a	-1.64M	-1.43M	-952K	n/a	n/a	-4.08M	n/a	n/a
Change in Working Capital	n/a	2.31M	-806K	875K	-2.78M	855K	-2.19M	2.37M	7.15M
Operating Cash Flow	-16.94M	-19M	-19.08M	-12.89M	-12.17M	-13.87M	-17.28M	-20.2M	-27.9M
Capital Expenditures	-1K	-202K	-116K	-14K	-9K	n/a	-7K	-212K	-569K
Cash Acquisitions	n/a	n/a	-4.28M	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	-417K	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	421.28K	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	-4.28K	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-1K	-202K	-4.4M	-14K	-9K	n/a	-7K	-212K	-569K
Debt Repayment	-67K	-75K	-1.38M	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	-288K	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	-1.52M	-3M	8.04M	n/a	n/a	n/a	166K	198K
Financial Cash Flow	5.5M	625K	-1.93M	74M	3.36M	n/a	29.09M	18.48M	26.71M
Net Cash Flow	-11.57M	-18.61M	-25.44M	61.1M	-8.82M	-13.87M	11.8M	-1.94M	-1.76M
Free Cash Flow	-16.94M	-19.2M	-19.2M	-12.9M	-12.18M	-13.87M	-17.29M	-20.42M	-28.47M